In addition, miR‐22 in vascular endothelial cells in NSCLC tissues directly targets sirtuin 1 and FGFR1, inactivating their common AKT/mTOR pathway to inhibit angiogenesis and tumor cell growth.161. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.